First Trust Indxx Metaverse ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell

43

ARVR
First Trust Indxx Metaverse ETF

Last Price:

$48.94

Seasonality Move:

5.91%

Sell

34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:

$53.22

Seasonality Move:

-13.28%

Sell

43

First Trust Indxx Metaverse ETF (ARVR) is a Sell

Is First Trust Indxx Metaverse ETF a Buy, Sell or Hold?

The current First Trust Indxx Metaverse ETF [ARVR] share price is $50.12. The Score for ARVR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
ARVR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

34

Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARVR Stock Price Chart

What is First Trust Indxx Metaverse ETF's stock price today?

The First Trust Indxx Metaverse ETF share price today is $50.12

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARVR is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

The Crinetics Pharmaceuticals, Inc. share price today is $53.24

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

ARVR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.25	Buy
Relative Strength Index (14 RSI):	56.6	Buy
Chaikin Money Flow:	-224	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(48.61 - 50.15)	Buy
Bollinger Bands (100):	(48.21 - 50.83)	Buy

CRNX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.28	Buy
Relative Strength Index (14 RSI):	65.68	Buy
Chaikin Money Flow:	-209678	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(46.25 - 50.15)	Buy
Bollinger Bands (100):	(35.32 - 47.44)	Buy

ARVR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	49.78	Buy
20-day SMA:	49.34	Buy
50-day SMA:	49.46	Buy
200-day SMA:	46.15	Buy
8-day EMA:	49.9	Buy
20-day EMA:	49.49	Buy
50-day EMA:	49.4	Buy
200-day EMA:	46.64	Buy

CRNX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.77	Buy
20-day SMA:	48.57	Buy
50-day SMA:	45.67	Buy
200-day SMA:	36.1	Buy
8-day EMA:	49.69	Buy
20-day EMA:	48.35	Buy
50-day EMA:	45.87	Buy
200-day EMA:	40.28	Buy

First Trust Indxx Metaverse ETF Earnings Growth & ARVR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

First Trust Indxx Metaverse ETF Technical Analysis

	Dec 22	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7	Jan 8
	Dec							Jan
	22	24	26	29	30	31	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

	Dec 23	Dec 24	Dec 26	Dec 29	Dec 30	Dec 31	Jan 5	Jan 6	Jan 7	Jan 8
	Dec							Jan
	23	24	26	29	30	31	05	06	07	08
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):